"Promising Results: Common Drug Provides Relief for Irritable Bowel Syndrome"
Originally Published 2 years ago — by SciTechDaily

The ATLANTIS trial has revealed that the commonly prescribed drug amitriptyline can significantly alleviate symptoms of irritable bowel syndrome (IBS), offering a new treatment option for patients. The study, conducted in primary care settings, found that patients taking amitriptyline were almost twice as likely to report an overall improvement in symptoms compared to those taking a placebo. The results support the use of low-dose amitriptyline as a second-line treatment for IBS in primary care, providing relief for patients who have not responded to first-line treatments.
